$EG
EVEREST GROUP, LTD. Stock $eg

$eg Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000109507322000005 Filed on February 28, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$3.120B	$11.87B	$222.3M
YoY Change	1303.37%	23.63%	52.21%
Cost Of Revenue		$7.391B
YoY Change		12.83%
Gross Profit		$4.475B
YoY Change		46.85%
Gross Profit Margin		37.71%
Selling, General & Admin	$619.1M	$2.277B	$525.0M
YoY Change	17.93%	18.92%	13.98%
% of Gross Profit		50.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.597B	$10.25B	$2.551B
YoY Change	1.8%	21.09%	28.37%
Operating Profit		-$5.775B
YoY Change		6.6%
Interest Expense	-$23.36M	-$70.15M	-$14.80M
YoY Change	57.86%	93.25%	92.21%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$500.1M	$1.546B	$119.4M
YoY Change	318.81%	164.05%	-45.5%
Income Tax	$69.36M	$166.5M	$57.30M
% Of Pretax Income	13.87%	10.77%	47.99%
Net Earnings	$430.7M	$1.379B	$63.60M
YoY Change	577.2%	168.23%	-70.78%
Net Earnings / Revenue	13.8%	11.62%	28.6%
Basic Earnings Per Share		$34.66	$1.59
Diluted Earnings Per Share	$11.09M	$34.62	$1.59
COMMON SHARES
Basic Shares Outstanding	39.37M shares	39.00M shares	39.97M shares
Diluted Shares Outstanding		39.30K shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$1.441B		$801.7M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment		$138.9M	$149.0M
YoY Change		-6.75%	-7.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.920B	$28.23B	$2.013B
YoY Change	45.09%	14.49%	14.12%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$38.19B	$38.19B	$32.71B
YoY Change	16.73%	16.46%	19.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$17.35M	$175.1M	$176.0M
YoY Change	-90.14%	-0.52%	1.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$34.05M	$191.8M	$383.0M
YoY Change	-91.11%	-49.93%	87.75%
LONG-TERM LIABILITIES
Long-Term Debt	$3.089B	$3.089B	$1.910B
YoY Change	61.71%	61.71%	201.26%
Other Long-Term Liabilities	$800.6M	$642.9M	$521.0M
YoY Change	53.66%	23.39%	52.79%
Total Long-Term Liabilities	$3.889B	$3.731B	$2.431B
YoY Change	59.98%	53.49%	149.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$34.05M	$191.8M	$383.0M
Total Long-Term Liabilities	$3.889B	$3.731B	$2.431B
Total Liabilities	$28.05B	$28.05B	$22.99B
YoY Change	22.02%	21.61%	26.35%
SHAREHOLDERS EQUITY
Retained Earnings	$11.70B		$10.57B
YoY Change	10.72%		2.53%
Common Stock	$698.0K		$696.0K
YoY Change	0.29%		0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.847B		$3.622B
YoY Change	6.22%		5.84%
Treasury Stock Shares	30.52M shares		29.64M shares
Shareholders Equity	$10.14B	$10.14B	$9.726B
YoY Change
Total Liabilities & Shareholders Equity	$38.19B	$38.19B	$32.71B
YoY Change	16.73%	16.46%	19.72%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$430.7M	$1.379B	$63.60M
YoY Change	577.2%	168.23%	-70.78%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$1.043B	$3.833B	$683.0M
YoY Change	52.68%	33.4%	87.07%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.767B	-$3.869B	-$1.954B
YoY Change	-9.56%	5.04%	873.64%
Cash From Investing Activities	-$1.767B	-$3.869B	-$1.954B
YoY Change	-9.56%	5.04%	873.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$225.1M
YoY Change		12.56%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.087B	$674.2M	1.137B
YoY Change	-4.36%	-15.75%	-2004.36%
NET CHANGE
Cash From Operating Activities	1.043B	$3.833B	683.0M
Cash From Investing Activities	-1.767B	-$3.869B	-1.954B
Cash From Financing Activities	1.087B	$674.2M	1.137B
Net Change In Cash	362.8M	$639.2M	-134.2M
YoY Change	-370.36%	-10111.12%	-228.18%
FREE CASH FLOW
Cash From Operating Activities	$1.043B	$3.833B	$683.0M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt		USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y7M6D
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001095073
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt		USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt		USD
CY2021	us-gaap	Liability For Asbestos And Environmental Claims Net Incurred Loss1 LiabilityForAsbestosAndEnvironmentalClaimsNetIncurredLoss1		USD
CY2019	us-gaap	Liability For Asbestos And Environmental Claims Net Incurred Loss1 LiabilityForAsbestosAndEnvironmentalClaimsNetIncurredLoss1		USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate		USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions		USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities		USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities		USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities		USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations		USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations		USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations		USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment		USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt		USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt		USD
CY2019	re	Proceeds From Payments For Fhlbank Advance ProceedsFromPaymentsForFhlbankAdvance		USD
CY2021	re	Contractual Commitments Investment Period Expiration Date ContractualCommitmentsInvestmentPeriodExpirationDate	2026-12-31
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y3M18D
CY2019	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt		USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal		USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss		USD
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	1-15731
CY2021	dei	Entity Registrant Name EntityRegistrantName	EVEREST RE GROUP, LTD.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0365432
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	Seon Place – 4
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	141 Front Street
CY2021	dei	Entity Address Address Line3 EntityAddressAddressLine3	PO Box HM 845
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Hamilton
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	HM 19
CY2021	dei	Entity Address Country EntityAddressCountry	BM
CY2021	dei	City Area Code CityAreaCode	441
CY2021	dei	Local Phone Number LocalPhoneNumber	295-0006
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021Q2	dei	Entity Public Float EntityPublicFloat	10100000000	USD
CY2021	dei	Security12b Title Security12bTitle	Common Shares, $0.01 par value
CY2021	dei	Trading Symbol TradingSymbol	RE
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39271864	shares
CY2021	dei	Auditor Firm AuditorFirmId	238
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Auditor Location AuditorLocation	New York, New York
CY2021Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	22308272000	USD
CY2020Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	20040173000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	29738000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1825908000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1472236000	USD
CY2021Q4	re	Other Short Term Investments Cost OtherShortTermInvestmentsCost	1178386000	USD
CY2020Q4	re	Other Short Term Investments Cost OtherShortTermInvestmentsCost	1135088000	USD
CY2021Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	1178337000	USD
CY2020Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	1134950000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2919965000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	2012581000	USD
CY2021Q4	us-gaap	Cash Cash	1440861000	USD
CY2020Q4	us-gaap	Cash Cash	801651000	USD
CY2021Q4	us-gaap	Investments And Cash InvestmentsAndCash	29673343000	USD
CY2020Q4	us-gaap	Investments And Cash InvestmentsAndCash	25461591000	USD
CY2021Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	149105000	USD
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	141304000	USD
CY2021Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	3293598000	USD
CY2020Q4	us-gaap	Premiums Receivable At Carrying Value PremiumsReceivableAtCarryingValue	2680562000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	2053354000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables On Paid Losses ReinsuranceRecoverablesOnPaidLosses	1994555000	USD
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	868601000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Asset FundsHeldUnderReinsuranceAgreementsAsset	716655000	USD
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	872289000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	622053000	USD
CY2021Q4	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	515445000	USD
CY2020Q4	us-gaap	Prepaid Reinsurance Premiums PrepaidReinsurancePremiums	412015000	USD
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	2381000	USD
CY2020Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	17253000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	757167000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	665515000	USD
CY2021Q4	us-gaap	Assets Assets	38185283000	USD
CY2020Q4	us-gaap	Assets Assets	32711503000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	19009486000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	16322143000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	35669000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	37723000	USD
CY2021Q4	us-gaap	Unearned Premiums UnearnedPremiums	4609634000	USD
CY2020Q4	us-gaap	Unearned Premiums UnearnedPremiums	3501359000	USD
CY2021Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	18391000	USD
CY2020Q4	us-gaap	Funds Held Under Reinsurance Agreements Liability FundsHeldUnderReinsuranceAgreementsLiability	15807000	USD
CY2021Q4	us-gaap	Reinsurance Payable ReinsurancePayable	449723000	USD
CY2020Q4	us-gaap	Reinsurance Payable ReinsurancePayable	294347000	USD
CY2021Q4	re	Loss In Course Of Payment LossInCourseOfPayment	260684000	USD
CY2020Q4	re	Loss In Course Of Payment LossInCourseOfPayment	127971000	USD
CY2021Q4	us-gaap	Senior Notes SeniorNotes	2345800000	USD
CY2020Q4	us-gaap	Senior Notes SeniorNotes	1376718000	USD
CY2021Q4	us-gaap	Subordinated Debt SubordinatedDebt	223774000	USD
CY2020Q4	us-gaap	Subordinated Debt SubordinatedDebt	223674000	USD
CY2021Q4	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	519000000	USD
CY2020Q4	us-gaap	Advances From Federal Home Loan Banks AdvancesFromFederalHomeLoanBanks	310000000	USD
CY2021Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	17348000	USD
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	10460000	USD
CY2021Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	16698000	USD
CY2020Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	206693000	USD
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	539896000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	558432000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	28046103000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	22985327000	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	506746000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69790000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69620000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	698000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	696000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2274431000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2245301000	USD
CY2021	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	26781000	USD
CY2020	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	80451000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	11523000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	534899000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	30524000	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	29636000	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3847308000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3622172000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11699836000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10567452000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10139180000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9726176000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	38185283000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32711503000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	10406441000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	8681513000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	7403686000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	1164892000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	642465000	USD
CY2019	us-gaap	Net Investment Income NetInvestmentIncome	647139000	USD
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	-27992000	USD
CY2020	us-gaap	Debt Securities Available For Sale Realized Gain Loss Excluding Other Than Temporary Impairment DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment	-1745000	USD
CY2021	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	285935000	USD
CY2020	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	269394000	USD
CY2019	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	205903000	USD
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	257943000	USD
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	267649000	USD
CY2019	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	185004000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	36987000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6487000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4660000	USD
CY2021	us-gaap	Revenues Revenues	11866263000	USD
CY2020	us-gaap	Revenues Revenues	9598114000	USD
CY2019	us-gaap	Revenues Revenues	8231169000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	7391253000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	6550837000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	4922898000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2208766000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1873250000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1703726000	USD
CY2021	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	582647000	USD
CY2020	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	511237000	USD
CY2019	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	440899000	USD
CY2021	re	Corporate Expenses CorporateExpenses	67827000	USD
CY2020	re	Corporate Expenses CorporateExpenses	41118000	USD
CY2019	re	Corporate Expenses CorporateExpenses	32966000	USD
CY2021	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	70149000	USD
CY2020	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	36323000	USD
CY2019	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	31693000	USD
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	10320642000	USD
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	9012765000	USD
CY2019	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	7132182000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1545621000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	585349000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1098987000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	166538000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71198000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89526000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	1379083000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	514151000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	1009461000	USD
CY2020	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	423210000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	496430000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	3476000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	12613000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-484762000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	419734000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	483817000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-62091000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	86327000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	14030000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-6251000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax	5615000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax	12591000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	-17227000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	-6300000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax	-5453000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-23478000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-685000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	7138000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-523375000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	490709000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	855708000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1500170000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	34.66
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	24.77
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	34.62
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	24.70
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	6.20
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	6.20
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	5.75
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10139180000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9726176000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	9132925000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	1379083000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	514151000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	1009461000	USD
CY2021	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	648735000	USD
CY2020	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	387123000	USD
CY2019	us-gaap	Increase Decrease In Premiums Receivable IncreaseDecreaseInPremiumsReceivable	62018000	USD
CY2021	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	151028000	USD
CY2020	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	219321000	USD
CY2019	us-gaap	Increase Decrease In Funds Held Under Reinsurance Agreements IncreaseDecreaseInFundsHeldUnderReinsuranceAgreements	56722000	USD
CY2021	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	124796000	USD
CY2020	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	150753000	USD
CY2019	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	-67444000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-68148000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-239883000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-237479000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	127792000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	-55334000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Reinsurance Premiums IncreaseDecreaseInPrepaidReinsurancePremiums	95207000	USD
CY2021	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	2805064000	USD
CY2020	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	2631016000	USD
CY2019	us-gaap	Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve	343254000	USD
CY2021	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-2054000	USD
CY2020	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-4869000	USD
CY2019	us-gaap	Increase Decrease In Future Policy Benefit Reserves IncreaseDecreaseInFuturePolicyBenefitReserves	-4186000	USD
CY2021	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	1145512000	USD
CY2020	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	404049000	USD
CY2019	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	521709000	USD
CY2021	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	185764000	USD
CY2020	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	-24163000	USD
CY2019	us-gaap	Increase Decrease In Reinsurance Payables IncreaseDecreaseInReinsurancePayables	66477000	USD
CY2021	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	133700000	USD
CY2020	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	74759000	USD
CY2019	re	Increase Decrease In Losses In Course Of Payment IncreaseDecreaseInLossesInCourseOfPayment	-33557000	USD
CY2021	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	612569000	USD
CY2020	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	103772000	USD
CY2019	re	Change In Equity Adjustments In Limited Partnerships ChangeInEquityAdjustmentsInLimitedPartnerships	108332000	USD
CY2021	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	211367000	USD
CY2020	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	122326000	USD
CY2019	us-gaap	Reimbursement From Limited Partnership Investment ReimbursementFromLimitedPartnershipInvestment	81300000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	289562000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	99171000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-4950000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	43406000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	39209000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	34018000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	75777000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	49673000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	30936000	USD
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	257943000	USD
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	267649000	USD
CY2019	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	185004000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3833342000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2873579000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1852002000	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3892918000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2586405000	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2302299000	USD
CY2021	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	1915916000	USD
CY2020	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	1945867000	USD
CY2019	re	Proceeds From Sale Of Available For Sale Securities Debt Market Value ProceedsFromSaleOfAvailableForSaleSecuritiesDebtMarketValue	3280237000	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4907000	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2917000	USD
CY2021	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	990376000	USD
CY2020	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	376347000	USD
CY2019	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	283965000	USD
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	257233000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	309912000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	284558000	USD
CY2021	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	8825315000	USD
CY2020	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	7189301000	USD
CY2019	re	Payments To Acquire Available For Sale Securities Debt Market Value PaymentsToAcquireAvailableForSaleSecuritiesDebtMarketValue	6613917000	USD
CY2019	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	4243000	USD
CY2021	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	1097886000	USD
CY2020	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	637082000	USD
CY2019	us-gaap	Payments To Acquire Equity Securities Fv Ni PaymentsToAcquireEquitySecuritiesFvNi	329417000	USD
CY2021	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	756560000	USD
CY2020	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	557473000	USD
CY2019	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	425438000	USD
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	42630000	USD
CY2020	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	717527000	USD
CY2019	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	167290000	USD
CY2021	re	Net Change In Unsettled Securities Transactions NetChangeInUnsettledSecuritiesTransactions	203016000	USD
CY2020	re	Net Change In Unsettled Securities Transactions NetChangeInUnsettledSecuritiesTransactions	-194574000	USD
CY2019	re	Net Change In Unsettled Securities Transactions NetChangeInUnsettledSecuritiesTransactions	26163000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3868964000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3683371000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1412492000	USD
CY2021	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	14275000	USD
CY2020	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	13566000	USD
CY2019	re	Payments For Shares Issued For Share Based Compensation Net Of Expense PaymentsForSharesIssuedForShareBasedCompensationNetOfExpense	3134000	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	225136000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	200020000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	24604000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	246699000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	249097000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	234322000	USD
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	968357000	USD
CY2020	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	979417000	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	10647000	USD
CY2021	re	Proceeds From Payments For Fhlbank Advance ProceedsFromPaymentsForFhlbankAdvance	209000000	USD
CY2020	re	Proceeds From Payments For Fhlbank Advance ProceedsFromPaymentsForFhlbankAdvance	310000000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	17054000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15908000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13627000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	674193000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	800220000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-275687000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	639000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3187000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-11882000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	639210000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6385000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	151941000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	801651000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	808036000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	656095000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1440861000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	801651000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	808036000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	98030000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-169748000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-148585000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	62369000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	28415000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	31689000	USD
CY2021	re	Reinsurance Recoverable Premium Receivables And Deductibles ReinsuranceRecoverablePremiumReceivablesAndDeductibles	46499000	USD
CY2020	re	Reinsurance Recoverable Premium Receivables And Deductibles ReinsuranceRecoverablePremiumReceivablesAndDeductibles	41357000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	1379083000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	514151000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	1009461000	USD
CY2021	re	Minimum Percent Of Prepaid Reinsurance Premiums For Any Foreign Reinsurers That Were Collateralized MinimumPercentOfPrepaidReinsurancePremiumsForAnyForeignReinsurersThatWereCollateralized	0.10	pure
CY2021	us-gaap	Dividends Common Stock DividendsCommonStock	246699000	USD
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	249056000	USD
CY2020	us-gaap	Undistributed Earnings UndistributedEarnings	265094000	USD
CY2019	us-gaap	Undistributed Earnings UndistributedEarnings	775139000	USD
CY2021	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2020	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2019	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.989	pure
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1117318000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	261770000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	766386000	USD
CY2021	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	243569000	USD
CY2020	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	246054000	USD
CY2019	re	Dividend Declared Common Shareholders DividendDeclaredCommonShareholders	231796000	USD
CY2021	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	1360887000	USD
CY2020	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	507824000	USD
CY2019	re	Numerator For Basic And Diluted Earnings Per Common Share NumeratorForBasicAndDilutedEarningsPerCommonShare	998182000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39263	shares
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39656	shares
CY2019	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	40291	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	41	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	77	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	129	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39304	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39734	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40420	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	34.66
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	24.77
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	34.62
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	24.70
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39656	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40291	shares
CY2021	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	39792	shares
CY2020	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	40160	shares
CY2019	re	Basic Weighted Average Common Shares Outstanding And Nonvested Common Shares Expected To Vest BasicWeightedAverageCommonSharesOutstandingAndNonvestedCommonSharesExpectedToVest	40751	shares
CY2021	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2020	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.987	pure
CY2019	re	Percentage Allocated To Common Shareholders PercentageAllocatedToCommonShareholders	0.989	pure
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	Item
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	22063592000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	477548000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	203130000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	22308272000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19225067000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	941663000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	124812000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	20040173000	USD
CY2021Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	22308272000	USD
CY2020Q4	re	Available For Sale Securities Debt Securities Market Value AvailableForSaleSecuritiesDebtSecuritiesMarketValue	20040173000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	8094261000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	127800000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	1240691000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	75330000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	9334952000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	203130000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2017481000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	67958000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	660968000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	56854000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	2678449000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	124812000	USD
CY2018Q4	us-gaap	Liability For Asbestos And Environmental Claims Net LiabilityForAsbestosAndEnvironmentalClaimsNet	261456000	USD
CY2020	us-gaap	Liability For Asbestos And Environmental Claims Net Incurred Loss1 LiabilityForAsbestosAndEnvironmentalClaimsNetIncurredLoss1	-772000	USD
CY2021	us-gaap	Liability For Asbestos And Environmental Claims Net Payment For Claims LiabilityForAsbestosAndEnvironmentalClaimsNetPaymentForClaims	42139000	USD
CY2020	us-gaap	Liability For Asbestos And Environmental Claims Net Payment For Claims LiabilityForAsbestosAndEnvironmentalClaimsNetPaymentForClaims	29674000	USD
CY2019	us-gaap	Liability For Asbestos And Environmental Claims Net Payment For Claims LiabilityForAsbestosAndEnvironmentalClaimsNetPaymentForClaims	32756000	USD
CY2021Q4	us-gaap	Liability For Asbestos And Environmental Claims Net LiabilityForAsbestosAndEnvironmentalClaimsNet	156115000	USD
CY2020Q4	us-gaap	Liability For Asbestos And Environmental Claims Net LiabilityForAsbestosAndEnvironmentalClaimsNet	198255000	USD
CY2021	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	1207905000	USD
CY2020	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	680703000	USD
CY2019	re	Gross Investment Income Before Adjustment GrossInvestmentIncomeBeforeAdjustment	677347000	USD
CY2021	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	12324000	USD
CY2020	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	12754000	USD
CY2019	re	Funds Held Interest Income Expense FundsHeldInterestIncomeExpense	13271000	USD
CY2021	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-1093000	USD
CY2020	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-1237000	USD
CY2019	re	Future Policy Benefit Reserve Income Expense FuturePolicyBenefitReserveIncomeExpense	-1380000	USD
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1219136000	USD
CY2020	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	692220000	USD
CY2019	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	689238000	USD
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	54244000	USD
CY2020	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	49755000	USD
CY2019	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	42099000	USD
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	1164892000	USD
CY2020	us-gaap	Investment Income Net InvestmentIncomeNet	642465000	USD
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	647139000	USD
CY2021Q4	re	Additional Contractual Commitments AdditionalContractualCommitments	2300000	USD
CY2021Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	2900000000	USD
CY2020Q4	us-gaap	Variable Interest Entity Entity Maximum Loss Exposure Amount VariableInterestEntityEntityMaximumLossExposureAmount	2000000000.0	USD
CY2021Q4	re	Commitments To Fund Investments CommitmentsToFundInvestments	2100000000	USD
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	257943000	USD
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	267649000	USD
CY2019	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	185004000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	28679000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	5293000	USD
CY2021	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-5979000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	29738000	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	32884000	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Purchased With Credit Deterioration Increase DebtSecuritiesAvailableForSaleAllowanceForCreditLossPurchasedWithCreditDeteriorationIncrease	6645000	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not To Sell Before Recovery Credit Loss Previously Recorded Expense Reversal DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotToSellBeforeRecoveryCreditLossPreviouslyRecordedExpenseReversal	-5525000	USD
CY2020	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Securities Sold DebtSecuritiesAvailableForSaleAllowanceForCreditLossSecuritiesSold	-32259000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss DebtSecuritiesAvailableForSaleAllowanceForCreditLoss	1745000	USD
CY2021Q4	us-gaap	Asset Backed Securities At Carrying Value AssetBackedSecuritiesAtCarryingValue	1500000000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	16322143000	USD
CY2019Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	13531256000	USD
CY2018Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	13098158000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1843691000	USD
CY2018Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1619641000	USD
CY2020Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	14478452000	USD
CY2019Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	11890544000	USD
CY2018Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	11478517000	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	7400303000	USD
CY2020	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	6149410000	USD
CY2019	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	4986456000	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-9050000	USD
CY2020	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	401427000	USD
CY2019	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-63558000	USD
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	7391253000	USD
CY2020	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	6550837000	USD
CY2019	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	4922898000	USD
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	2490645000	USD
CY2020	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	2046260000	USD
CY2019	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	2042246000	USD
CY2021	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	2226457000	USD
CY2020	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	2077613000	USD
CY2019	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	2519950000	USD
CY2021	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	4717102000	USD
CY2020	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	4123873000	USD
CY2019	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	4562196000	USD
CY2021	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	-89481000	USD
CY2020	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	160944000	USD
CY2019	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	51325000	USD
CY2021Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	17063121000	USD
CY2020Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	14478452000	USD
CY2019Q4	re	Reserve For Losses And Loss Adjustment Expenses Net ReserveForLossesAndLossAdjustmentExpensesNet	11890544000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1946365000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1843691000	USD
CY2019Q4	us-gaap	Reinsurance Recoverables ReinsuranceRecoverables	1640712000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	19009486000	USD
CY2020Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	16322143000	USD
CY2019Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	13531256000	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	7400000000	USD
CY2020	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	6100000000	USD
CY2019	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	5000000000.0	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-9100000	USD
CY2020	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	401400000	USD
CY2019	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-63600000	USD
CY2021	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-9100000	USD
CY2021Q4	us-gaap	Shortduration Insurance Contracts Liability For Unpaid Claims And Allocated Claim Adjustment Expense Net ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet	16785529000	USD
CY2021Q4	us-gaap	Reinsurance Recoverable For Unpaid Claims And Claims Adjustments ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments	1946365000	USD
CY2021Q4	us-gaap	Shortduration Insurance Contracts Liability For Unpaid Claims And Claims Adjustment Expense Accumulated Unallocated Claim Adjustment Expense ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAccumulatedUnallocatedClaimAdjustmentExpense	235391000	USD
CY2021Q4	us-gaap	Shortduration Insurance Contracts Liability For Unpaid Claims And Claim Adjustment Expense Other Reconciling Item ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem	42199000	USD
CY2021Q4	re	Short Duration Insurance Contracts Liability For Unpaid Claims And Claims Adjustment Expense ShortDurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	277590000	USD
CY2021Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	19009486000	USD
CY2021	re	Number Of Exposure Groups NumberOfExposureGroups	200	Item
CY2021	re	Expiry Of Asbestos And Environmental Claims Receivables Years ExpiryOfAsbestosAndEnvironmentalClaimsReceivablesYears	P20Y
CY2020Q4	us-gaap	Liability For Asbestos And Environmental Claims Gross LiabilityForAsbestosAndEnvironmentalClaimsGross	219341000	USD
CY2019Q4	us-gaap	Liability For Asbestos And Environmental Claims Gross LiabilityForAsbestosAndEnvironmentalClaimsGross	257921000	USD
CY2018Q4	us-gaap	Liability For Asbestos And Environmental Claims Gross LiabilityForAsbestosAndEnvironmentalClaimsGross	347495000	USD
CY2021	re	Liability For Asbestos And Environmental Claims Gross Incurred Loss LiabilityForAsbestosAndEnvironmentalClaimsGrossIncurredLoss	10862000	USD
CY2020	re	Liability For Asbestos And Environmental Claims Gross Incurred Loss LiabilityForAsbestosAndEnvironmentalClaimsGrossIncurredLoss	1540000	USD
CY2019	re	Liability For Asbestos And Environmental Claims Gross Incurred Loss LiabilityForAsbestosAndEnvironmentalClaimsGrossIncurredLoss	2070000	USD
CY2021	us-gaap	Liability For Asbestos And Environmental Claims Gross Payment For Claims LiabilityForAsbestosAndEnvironmentalClaimsGrossPaymentForClaims	55048000	USD
CY2020	us-gaap	Liability For Asbestos And Environmental Claims Gross Payment For Claims LiabilityForAsbestosAndEnvironmentalClaimsGrossPaymentForClaims	40120000	USD
CY2019	us-gaap	Liability For Asbestos And Environmental Claims Gross Payment For Claims LiabilityForAsbestosAndEnvironmentalClaimsGrossPaymentForClaims	91644000	USD
CY2021Q4	us-gaap	Liability For Asbestos And Environmental Claims Gross LiabilityForAsbestosAndEnvironmentalClaimsGross	175155000	USD
CY2020Q4	us-gaap	Liability For Asbestos And Environmental Claims Gross LiabilityForAsbestosAndEnvironmentalClaimsGross	219341000	USD
CY2019Q4	us-gaap	Liability For Asbestos And Environmental Claims Gross LiabilityForAsbestosAndEnvironmentalClaimsGross	257921000	USD
CY2020Q4	us-gaap	Liability For Asbestos And Environmental Claims Net LiabilityForAsbestosAndEnvironmentalClaimsNet	198255000	USD
CY2019Q4	us-gaap	Liability For Asbestos And Environmental Claims Net LiabilityForAsbestosAndEnvironmentalClaimsNet	228701000	USD
CY2019Q4	us-gaap	Liability For Asbestos And Environmental Claims Net LiabilityForAsbestosAndEnvironmentalClaimsNet	228701000	USD
CY2015	re	Liabilities Retroceded Percentage LiabilitiesRetrocededPercentage	1	pure
CY2015	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	140300000	USD
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	440300000	USD
CY2015	re	Total Amount Of Liabilities Retroceded TotalAmountOfLiabilitiesRetroceded	300000000.0	USD
CY2020	re	Increase Decrease In Amount Of Liabilities Retroceded IncreaseDecreaseInAmountOfLiabilitiesRetroceded	-43400000	USD
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	450300000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	2100000000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables On Paid And Unpaid Losses ReinsuranceRecoverablesOnPaidAndUnpaidLosses	2000000000.0	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	37723000	USD
CY2019Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	42592000	USD
CY2018Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	46778000	USD
CY2021	us-gaap	Liability For Future Policy Benefits Period Expense LiabilityForFuturePolicyBenefitsPeriodExpense	27000	USD
CY2020	us-gaap	Liability For Future Policy Benefits Period Expense LiabilityForFuturePolicyBenefitsPeriodExpense	35000	USD
CY2019	us-gaap	Liability For Future Policy Benefits Period Expense LiabilityForFuturePolicyBenefitsPeriodExpense	53000	USD
CY2021	us-gaap	Liability For Future Policy Benefits Period Increase Decrease LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease	719000	USD
CY2020	us-gaap	Liability For Future Policy Benefits Period Increase Decrease LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease	-1113000	USD
CY2019	us-gaap	Liability For Future Policy Benefits Period Increase Decrease LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease	350000	USD
CY2021	us-gaap	Liability For Future Policy Benefits Payment For Benefits LiabilityForFuturePolicyBenefitsPaymentForBenefits	2800000	USD
CY2020	us-gaap	Liability For Future Policy Benefits Payment For Benefits LiabilityForFuturePolicyBenefitsPaymentForBenefits	3791000	USD
CY2019	us-gaap	Liability For Future Policy Benefits Payment For Benefits LiabilityForFuturePolicyBenefitsPaymentForBenefits	4589000	USD
CY2021Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	35669000	USD
CY2020Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	37723000	USD
CY2019Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	42592000	USD
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1825908000	USD
CY2020Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1472236000	USD
CY2021Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1200000000	USD
CY2021Q4	re	Line Of Credit Facility Uncommited Amount Available LineOfCreditFacilityUncommitedAmountAvailable	340000000.0	USD
CY2021	us-gaap	Lease Cost LeaseCost	26540000	USD
CY2020	us-gaap	Lease Cost LeaseCost	32508000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	138942000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	149125000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	157729000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	165292000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	18294000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	20594000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0408	pure
CY2021	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	5818000	USD
CY2020	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	7645000	USD
CY2019	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	11587000	USD
CY2021Q4	us-gaap	Security Deposit SecurityDeposit	1700000000	USD
CY2021Q4	us-gaap	Reinsurance Recoverables Gross ReinsuranceRecoverablesGross	206100000	USD
CY2020Q4	us-gaap	Reinsurance Recoverables Gross ReinsuranceRecoverablesGross	254900000	USD
CY2021Q4	re	Reinsurance Deferred Gain Liability ReinsuranceDeferredGainLiability	15500000	USD
CY2020Q4	re	Reinsurance Deferred Gain Liability ReinsuranceDeferredGainLiability	38800000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0410	pure
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	20865000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	20238000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	20016000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	17025000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	15805000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	108793000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	202742000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	45013000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	157729000	USD
CY2019Q3	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	315000	sqft
CY2021	re	Operating Lease Expense Expiration Date Year OperatingLeaseExpenseExpirationDateYear	2036
CY2021	re	Operating Lease Expense Monthly Lease OperatingLeaseExpenseMonthlyLease	650000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	7800000	USD
CY2021	re	Accrual Withholding Taxes Percent AccrualWithholdingTaxesPercent	0.05	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	123876000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-107757000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-5044000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2038000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2948000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	14420000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	125914000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-104809000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9376000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	37597000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	178523000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	80247000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3027000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2516000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-97000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	40624000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	176007000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	80150000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	166538000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71198000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	89526000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8434000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	8434000	USD
CY2021Q4	re	Income Tax Examination Penalties And Interest Accrued Net Of Federal Benefit IncomeTaxExaminationPenaltiesAndInterestAccruedNetOfFederalBenefit	0	USD
CY2020Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2021Q4	us-gaap	Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority	-16300000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	129861000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	96840000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	107724000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	85028000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	30885000	USD
CY2021	us-gaap	Ceded Premiums Written CededPremiumsWritten	1604251000	USD
CY2020	us-gaap	Ceded Premiums Written CededPremiumsWritten	1365378000	USD
CY2019	us-gaap	Ceded Premiums Written CededPremiumsWritten	1308940000	USD
CY2021	us-gaap	Premiums Written Net PremiumsWrittenNet	11445505000	USD
CY2020	us-gaap	Premiums Written Net PremiumsWrittenNet	9116983000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	31989000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21787000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	46109000	USD
CY2021Q4	re	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	20228000	USD
CY2020Q4	re	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	33504000	USD
CY2021Q4	re	Deferred Tax Assets Net Unrecognized Losses On Benefit Plans DeferredTaxAssetsNetUnrecognizedLossesOnBenefitPlans	13395000	USD
CY2020Q4	re	Deferred Tax Assets Net Unrecognized Losses On Benefit Plans DeferredTaxAssetsNetUnrecognizedLossesOnBenefitPlans	19636000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	7558000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	7367000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	6160000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	1121000	USD
CY2021Q4	re	Deferred Tax Assets Uncollectible Reinsurance DeferredTaxAssetsUncollectibleReinsurance	4486000	USD
CY2020Q4	re	Deferred Tax Assets Uncollectible Reinsurance DeferredTaxAssetsUncollectibleReinsurance	603000	USD
CY2021Q4	re	Deferred Tax Assets Investment Impairments DeferredTaxAssetsInvestmentImpairments	3142000	USD
CY2020Q4	re	Deferred Tax Assets Investment Impairments DeferredTaxAssetsInvestmentImpairments	3142000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	213000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	4591000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	8973000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	7285000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	354412000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	337215000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	99395000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	79994000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	97974000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost	75692000	USD
CY2021Q4	re	Deferred Tax Liabilities Fair Value Adjustments DeferredTaxLiabilitiesFairValueAdjustments	56699000	USD
CY2020Q4	re	Deferred Tax Liabilities Fair Value Adjustments DeferredTaxLiabilitiesFairValueAdjustments	26119000	USD
CY2021Q4	re	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	36615000	USD
CY2020Q4	re	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	90268000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	27111000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Investment In Noncontrolled Affiliates DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates	28822000	USD
CY2021Q4	re	Deferred Tax Liabilities Deferred Expense Compensation And Benefits Pensions DeferredTaxLiabilitiesDeferredExpenseCompensationAndBenefitsPensions	1667000	USD
CY2020Q4	re	Deferred Tax Liabilities Deferred Expense Compensation And Benefits Pensions DeferredTaxLiabilitiesDeferredExpenseCompensationAndBenefitsPensions	1765000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	9963000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6710000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	329424000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	309370000	USD
CY2021Q4	re	Deferred Tax Assets Liabilities Net Before Valuation Allowance DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance	24988000	USD
CY2020Q4	re	Deferred Tax Assets Liabilities Net Before Valuation Allowance DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance	27845000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17765000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28805000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7223000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	960000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	28800000	USD
CY2021	us-gaap	Direct Premiums Written DirectPremiumsWritten	3987875000	USD
CY2020	us-gaap	Direct Premiums Written DirectPremiumsWritten	3217999000	USD
CY2019	us-gaap	Direct Premiums Written DirectPremiumsWritten	2783036000	USD
CY2021	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	9061881000	USD
CY2020	us-gaap	Assumed Premiums Written AssumedPremiumsWritten	7264362000	USD
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	754174000	USD
CY2019	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	619086000	USD
CY2021	re	Approval Of Authority For Dividend Payments Percentage Exceeds In Prior Year End Total Statutory Capital ApprovalOfAuthorityForDividendPaymentsPercentageExceedsInPriorYearEndTotalStatutoryCapital	0.25	pure
CY2019	us-gaap	Premiums Written Net PremiumsWrittenNet	7824424000	USD
CY2021	us-gaap	Direct Premiums Earned DirectPremiumsEarned	3588926000	USD
CY2020	us-gaap	Direct Premiums Earned DirectPremiumsEarned	3028095000	USD
CY2019	us-gaap	Direct Premiums Earned DirectPremiumsEarned	2551662000	USD
CY2021	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	8315072000	USD
CY2020	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	7054680000	USD
CY2019	us-gaap	Assumed Premiums Earned AssumedPremiumsEarned	6059222000	USD
CY2021	us-gaap	Ceded Premiums Earned CededPremiumsEarned	1497557000	USD
CY2020	us-gaap	Ceded Premiums Earned CededPremiumsEarned	1401262000	USD
CY2019	us-gaap	Ceded Premiums Earned CededPremiumsEarned	1207198000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	10406441000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	8681513000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	7403686000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	2384960000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	2141065000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Gross PolicyholderBenefitsAndClaimsIncurredGross	1618686000	USD
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	5741109000	USD
CY2020	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	5163946000	USD
CY2019	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Assumed ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed	3923298000	USD
CY2021	us-gaap	Reinsurance Effect On Claims And Benefits Incurred Amount Ceded ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded	734816000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	7391253000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	6550837000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	4922898000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-577045000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-53670000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-523375000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	556201000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	49455000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	542400000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	51691000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	490709000	USD
CY2021	re	Dividend Payment Restrictions Period DividendPaymentRestrictionsPeriod	P12M
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	87.87
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	3821000	USD
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	6825000	USD
CY2019	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	4750000	USD
CY2021Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	351550000	USD
CY2020Q4	us-gaap	Defined Benefit Plan Accumulated Benefit Obligation DefinedBenefitPlanAccumulatedBenefitObligation	352285000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	2540000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	374585000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	1204000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	349867000	USD
CY2021Q4	re	Minimum Solvency Margin MinimumSolvencyMargin	300000	USD
CY2021	re	Dividend Payment Restrictions Percentage Of Statutory Surplus Required DividendPaymentRestrictionsPercentageOfStatutorySurplusRequired	0.10	pure
CY2021	re	Minimum Percent Of Total Adjusted Capital MinimumPercentOfTotalAdjustedCapital	2	pure
CY2021	re	Minimum Percent Of Total Adjusted Capital MinimumPercentOfTotalAdjustedCapital	2	pure
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	43400000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	39200000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	34000000.0	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8000000.0	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	7100000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	8400000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	600000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	600000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	500000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	116871	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	87.87
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	67843	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	87.39
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	49028	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	88.52
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y2M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9090000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	49028	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	88.52
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y2M12D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9090000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	170704	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	87.18
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	53833	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	85.69
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	116871	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	87.87
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y8M12D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17089000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	116871	shares
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y8M12D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	17089000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	279164	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	83.84
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	108460	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	78.58
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	170704	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	87.18
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y4M24D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	32376000	USD
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	170704	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	87.18
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y4M24D
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	32376000	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	49028	shares
CY2021	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P0Y2M12D
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	88.52
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	49028	shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	88.52
CY2021	re	Unrecognized Compensation Cost Related To Non Vested Share Based Compensation Expense UnrecognizedCompensationCostRelatedToNonVestedShareBasedCompensationExpense	90900000	USD
CY2021	re	Unrecognized Compensation Cost Expected To Be Recognized Over Weighted Average Period UnrecognizedCompensationCostExpectedToBeRecognizedOverWeightedAveragePeriod	P3Y3M18D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	37900000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	38700000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	28100000	USD
CY2021	re	Tax Benefit From Stock Options Vested TaxBenefitFromStockOptionsVested	7500000	USD
CY2021	us-gaap	Premiums Written Gross PremiumsWrittenGross	13049756000	USD
CY2021	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	582647000	USD
CY2021	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	223775000	USD
CY2019	us-gaap	Premiums Written Gross PremiumsWrittenGross	9133364000	USD
CY2019	us-gaap	Premiums Written Net PremiumsWrittenNet	7824424000	USD
CY2021	us-gaap	Premiums Written Net PremiumsWrittenNet	11445505000	USD
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	10406441000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	7391253000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2208766000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	1164892000	USD
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	257943000	USD
CY2021	re	Corporate Expenses CorporateExpenses	67827000	USD
CY2021	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	70149000	USD
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	36987000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1545621000	USD
CY2020	us-gaap	Premiums Written Gross PremiumsWrittenGross	10482361000	USD
CY2020	us-gaap	Premiums Written Net PremiumsWrittenNet	9116983000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	8681513000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	6550837000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1873250000	USD
CY2020	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	511237000	USD
CY2020	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	-253811000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	642465000	USD
CY2020	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	267649000	USD
CY2020	re	Corporate Expenses CorporateExpenses	41118000	USD
CY2020	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	36323000	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	6487000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	585349000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	7403686000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	4922898000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1703726000	USD
CY2019	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	440899000	USD
CY2019	us-gaap	Underwriting Income Loss UnderwritingIncomeLoss	336163000	USD
CY2019	us-gaap	Net Investment Income NetInvestmentIncome	647139000	USD
CY2019	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	185004000	USD
CY2019	re	Corporate Expenses CorporateExpenses	32966000	USD
CY2019	re	Interest Fee And Bond Issue Cost Amortization Expense InterestFeeAndBondIssueCostAmortizationExpense	31693000	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4660000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1098987000	USD
CY2021	re	Percentage Threshold Of Company Revenue Not Exceeded By Any Other Country PercentageThresholdOfCompanyRevenueNotExceededByAnyOtherCountry	0.205	pure
CY2020	re	Percentage Threshold Of Company Revenue Not Exceeded By Any Other Country PercentageThresholdOfCompanyRevenueNotExceededByAnyOtherCountry	0.201	pure
CY2019	re	Percentage Threshold Of Company Revenue Not Exceeded By Any Other Country PercentageThresholdOfCompanyRevenueNotExceededByAnyOtherCountry	0.231	pure
CY2021Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Cost SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCost	28968319000	USD
CY2021Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Fair Value SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesFairValue	29673343000	USD
CY2021Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	29673343000	USD
CY2021	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	26781000	USD
CY2020	re	Accumulated Other Comprehensive Income Loss Tax AccumulatedOtherComprehensiveIncomeLossTax	80451000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	872289000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	19009486000	USD
CY2021Q4	us-gaap	Supplementary Insurance Information Unearned Premiums SupplementaryInsuranceInformationUnearnedPremiums	4609634000	USD
CY2021	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	10406441000	USD
CY2021	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	1164892000	USD
CY2021	us-gaap	Supplementary Insurance Information Benefits Claims Losses And Settlement Expense SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense	7391253000	USD
CY2021	us-gaap	Supplementary Insurance Information Amortization Of Deferred Policy Acquisition Costs SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts	2208766000	USD
CY2021	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	582647000	USD
CY2021	us-gaap	Supplementary Insurance Information Premiums Written SupplementaryInsuranceInformationPremiumsWritten	11445505000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	622053000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	16398997000	USD
CY2020Q4	us-gaap	Supplementary Insurance Information Unearned Premiums SupplementaryInsuranceInformationUnearnedPremiums	3501359000	USD
CY2020	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	8681513000	USD
CY2020	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	642465000	USD
CY2020	us-gaap	Supplementary Insurance Information Benefits Claims Losses And Settlement Expense SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense	6550837000	USD
CY2020	us-gaap	Supplementary Insurance Information Amortization Of Deferred Policy Acquisition Costs SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts	1873250000	USD
CY2020	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	511237000	USD
CY2020	us-gaap	Supplementary Insurance Information Premiums Written SupplementaryInsuranceInformationPremiumsWritten	9116983000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Deferred Policy Acquisition Costs SupplementaryInsuranceInformationDeferredPolicyAcquisitionCosts	581863000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	13611313000	USD
CY2019Q4	us-gaap	Supplementary Insurance Information Unearned Premiums SupplementaryInsuranceInformationUnearnedPremiums	3056735000	USD
CY2019	us-gaap	Supplementary Insurance Information Premium Revenue SupplementaryInsuranceInformationPremiumRevenue	7403686000	USD
CY2019	us-gaap	Supplementary Insurance Information Net Investment Income SupplementaryInsuranceInformationNetInvestmentIncome	647139000	USD
CY2019	us-gaap	Supplementary Insurance Information Benefits Claims Losses And Settlement Expense SupplementaryInsuranceInformationBenefitsClaimsLossesAndSettlementExpense	4922898000	USD
CY2019	us-gaap	Supplementary Insurance Information Amortization Of Deferred Policy Acquisition Costs SupplementaryInsuranceInformationAmortizationOfDeferredPolicyAcquisitionCosts	1703726000	USD
CY2019	us-gaap	Supplementary Insurance Information Other Operating Expense SupplementaryInsuranceInformationOtherOperatingExpense	440899000	USD
CY2019	us-gaap	Supplementary Insurance Information Premiums Written SupplementaryInsuranceInformationPremiumsWritten	7824424000	USD

Files In Submission

Name	View Source	Status
0001095073-22-000005-index-headers.html	Edgar Link	pending
0001095073-22-000005-index.html	Edgar Link	pending
0001095073-22-000005.txt	Edgar Link	pending
0001095073-22-000005-xbrl.zip	Edgar Link	pending
exhibit1039.htm	Edgar Link	pending
exhibit1040.htm	Edgar Link	pending
exhibit1040x0x0.jpg	Edgar Link	pending
exhibit1040x1x0.jpg	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit211x0x0.jpg	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
exhibit311.htm	Edgar Link	pending
exhibit312.htm	Edgar Link	pending
exhibit321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_000.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
re-20211231.htm	Edgar Link	pending
re-20211231.xsd	Edgar Link	pending
re-20211231_cal.xml	Edgar Link	unprocessable
re-20211231_def.xml	Edgar Link	unprocessable
re-20211231_htm.xml	Edgar Link	completed
re-20211231_lab.xml	Edgar Link	unprocessable
re-20211231_pre.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EG
EVEREST GROUP, LTD. Stock $eg

2021 Q4 Form 10-K Financial Statement

#000109507322000005 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EG EVEREST GROUP, LTD. Stock $eg

2021 Q4 Form 10-K Financial Statement

#000109507322000005 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EG
EVEREST GROUP, LTD. Stock $eg